Bear thank you for the link to this patent

The low HDL diabetic patient is the exact target of the BETonMACE Trial. From the presentation in New York City Sept 2015 it was suggested that there are 18 million people in the G8 countries that fit this exact profile. I will be shocked if there is not some form of CVR type deal made within a week of a positive Futility Study results being announced.

Eagerly awaiting 1) results of the meeting with the FDA in a few days and 2) the results of the Futility Study

tada